hypertension, portal
Showing 1 - 25 of 25
Hypertension, Portal, Liver Cirrhosis Trial (Placebo, BI 685509)
Not yet recruiting
- Hypertension, Portal
- Liver Cirrhosis
- Placebo
- BI 685509
- (no location specified)
Oct 9, 2023
Liver Diseases, Hypertension, Portal Trial in Wien, Montreal (BI 685509, Empagliflozin)
Recruiting
- Liver Diseases
- Hypertension, Portal
- BI 685509
- Empagliflozin
-
Pasadena, California
- +27 more
Jan 24, 2023
Hypertension, Portal, Ascites Trial in Los Angeles (Gore® Viatorr® Endoprosthesis with controlled expansion, Large Volume
Recruiting
- Hypertension, Portal
- Ascites
- Gore® Viatorr® Endoprosthesis with controlled expansion
- Large Volume Paracentesis with albumin infusion
-
Los Angeles, CaliforniaUCLA Medical Center
Sep 1, 2022
Endoscopic Ultrasound-Guided Portosystemic Pressure Gradient
Completed
- Liver Cirrhosis
- +2 more
- EchoTip® Insight™ Portosystemic Pressure Gradient Measurement System (EchoTip® Insight™)
-
Orange, California
- +6 more
Jun 17, 2022
Cirrhosis, Splenectomy, Venous Thrombosis Trial in Yangzhou (Apixaban 2.5 MG, Dipyridamole 25Mg Tab, subcutaneous Low Molecular
Recruiting
- Cirrhosis
- +3 more
- Apixaban 2.5 MG
- +2 more
-
Yangzhou, Jiangsu, ChinaClinical Medical College, Yangzhou University
Apr 30, 2022
Cirrhosis, Splenectomy; Status, Venous Thrombosis Trial in Yangzhou (Apixaban, Warfarin, Aspirin)
Recruiting
- Cirrhosis
- +3 more
- Apixaban
- +4 more
-
Yangzhou, Jiangsu, ChinaClinical Medical College of Yangzhou University
Mar 19, 2022
Hypertension, Portal Trial in Philadelphia (SHAPE measurement using the ultrasound contrast agent Sonazoid (perfluorobutane
Recruiting
- Hypertension, Portal
- SHAPE measurement using the ultrasound contrast agent Sonazoid (perfluorobutane microbubbles)
- SHAPE measurement using the ultrasound contrast agent Lumason (sulfur hexafluoride lipid-type A microspheres)
-
Philadelphia, PennsylvaniaThe Children's Hospital of Philadelphia
Jan 20, 2022
TIPS Plus Transvenous Obliteration for Gastric Varices
Recruiting
- Cirrhosis, Liver
- +4 more
- TIPS-obliteration
-
Chicago, IllinoisUniversity of Illinois at Chicago
Nov 18, 2021
Multiparametric Cardio-hepatic MRI in Noncirrhotic Portal
Recruiting
- Hypertension, Portal
- Cardiomyopathies
- Cardiac magnetic resonance scan
-
Bonn, NRW, Germany
- +1 more
Sep 2, 2021
Portal Hypertension in Cirrhosis (Pan-CHESS1802)
Recruiting
- Hypertension, Portal
- HVPG measurement
-
Beijing, China
- +5 more
Aug 16, 2021
Hypertension, Portal Trial in United States (GR-MD-02, Placebo)
Outcome After TIPS
Completed
- Hypertension, Portal
- +3 more
- no intervention - retrospective analyses
-
Graz, AustriaMedical University of Graz
May 14, 2020
Hypertension, Portal Trial in China, Turkey (Transjugular HVPG measurement, MR imaging)
Completed
- Hypertension, Portal
- Transjugular HVPG measurement
- MR imaging
-
Beijing, Beijing, China
- +10 more
Aug 26, 2019
Hypertension, Portal Trial in China (HVPG measurement, CTA)
Completed
- Hypertension, Portal
- HVPG measurement
- CTA
-
Beijing, Beijing, China
- +5 more
Jan 4, 2019
Hypertension, Portal Trial in China (Invasive PPG)
Withdrawn
- Hypertension, Portal
- Invasive PPG
-
Beijing, Beijing, China
- +9 more
Jan 4, 2019
Hypertension, Portal Trial in Beijing, Guangzhou (HVPG measurement, CTA, Doppler ultrasound)
Completed
- Hypertension, Portal
- HVPG measurement
- +2 more
-
Beijing, Beijing, China
- +2 more
Jan 4, 2019
Liver Cirrhosis, Hypertension, Portal Trial in Shanghai (HVPG measurement)
Unknown status
- Liver Cirrhosis
- Hypertension, Portal
- HVPG measurement
-
Shanghai, ChinaShanghai Ninth People's Hospital, Shanghai Jiao Tong University
Dec 12, 2018
Liver Cirrhosis, Hypertension, Portal Trial in Edinburgh (Serelaxin, Placebo)
Completed
- Liver Cirrhosis
- Hypertension, Portal
- Serelaxin
- Placebo
-
Edinburgh, United KingdomLiver Unit, Royal Infirmary of Edinburgh
Oct 10, 2018
Hypertension, Portal Trial in Ulm (ARFI-elastography and portal vein flow measurement, HVPG-measurement)
Unknown status
- Hypertension, Portal
- ARFI-elastography and portal vein flow measurement
- HVPG-measurement
-
Ulm, GermanyUniversitätsklinikum Ulm
Oct 16, 2017
Hypertension, Portal, Portal Vein, Cavernous Transformation Of Trial in Guangzhou (Percutaneous transhepatic intrahepatic
Unknown status
- Hypertension, Portal
- Portal Vein, Cavernous Transformation Of
- Percutaneous transhepatic intrahepatic portosystemic shunt
-
Guangzhou, Guangdong, ChinaDepartment of Radiology
Nov 10, 2015
Portal Vein, Cavernous Transformation Of, Hypertension, Portal Trial in Guangzhou (Transhepatic portosystemic shunt, 6-French
Unknown status
- Portal Vein, Cavernous Transformation Of
- Hypertension, Portal
- Transhepatic portosystemic shunt
- +6 more
-
Guangzhou, Guangdong, ChinaDepartment of Radiology
Jul 20, 2015
Follow-up Study of Complications of Acute Pancreatitis
Unknown status
- Pancreatitis
- +5 more
-
Nanchang, Jiangxi, Chinathe First Affiliated Hospital of Nanchang University
May 21, 2015
Esophageal and Gastric Varices, Ulcer, Cirrhosis Trial in Tanta (Esophagogastroduodenoscope)
Unknown status
- Esophageal and Gastric Varices
- +3 more
- Esophagogastroduodenoscope
-
Tanta, Gharbia, EgyptTanta University Hospital
Oct 2, 2014
Hepatic Encephalopathy, Hypertension, Portal, Liver Cirrhosis Trial in Botucatu (Erythromycin, Neomycin)
Unknown status
- Hepatic Encephalopathy
- +2 more
-
Botucatu, São Paulo, BrazilFaculdade de Medicina de Botucatu - Universidade Estadual Paulis
Apr 27, 2010